Indonesia vs Nepal: Share of E. coli infections resistant to cephalosporins
Indonesia
69.7%
in 2022
Nepal
77.1%
in 2022
Indonesia rank
8th
Nepal rank
5th
Share of E. coli infections resistant to cephalosporins over time
- Indonesia
- Nepal
How they compare
Nepal currently reports 77.1% against 69.7% in Indonesia, a difference of 7.4%.
That makes Nepal's figure about 1.1 times Indonesia's.
The two have swapped places 3 times across 5 shared years of data; in 2018 it was Indonesia ahead.
Indonesia ranks 8th and Nepal ranks 5th of 46 countries.
Nepal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.0% | 71.3% | 0.3% | Nepal |
| 2020s | 72.2% | 76.8% | 4.7% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Indonesia or Nepal?
- Nepal, at 77.1% against 69.7% in Indonesia as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Indonesia and Nepal?
- 7.4%, with Nepal ahead.
- How many years of comparable data are there for Indonesia and Nepal?
- 5 years are reported by both, from 2018 to 2022.
- How do Indonesia and Nepal rank globally for share of e. coli infections resistant to cephalosporins?
- Indonesia ranks 8th and Nepal ranks 5th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).